[Clinical and mycological evaluation of onychomycosis among Brazilian HIV/AIDS patients].
Autor: | Cambuim II; Departamento de Micologia, Universidade Federal de Pernambuco, Recife, PE., Macêdo DP, Delgado M, Lima Kde M, Mendes GP, Souza-Motta CM, Lima DM, Fernandes MJ, Magalhães OM, Queiroz LA, Neves RP |
---|---|
Jazyk: | portugalština |
Zdroj: | Revista da Sociedade Brasileira de Medicina Tropical [Rev Soc Bras Med Trop] 2011 Jan-Feb; Vol. 44 (1), pp. 40-2. |
DOI: | 10.1590/s0037-86822011000100010 |
Abstrakt: | Introduction: Onychomycosis is common in immunocompromised patients, but emerging species have been verified, thereby modifying the epidemiological profile of this mycosis. Thus, the aim of this study was to evaluate clinical and mycological profile of onychomycosis among HIV/AIDS patients. Methods: Clinical samples were collected and processed for direct examination, and cultures were maintained at a temperature of 30 °C and 37 °C for 15 days. Results: Out of 100 patients, 32 had onychomycosis. The etiological agents isolated were Candida albicans, C. parapsilosis, C. tropicalis, C. guilliermondii, Trichophyton rubrum, T. mentagrophytes, Fusarium solani, Scytalidium hialinum, S. japonicum, Aspergillus niger, Cylindrocarpon destructans and Phialophora reptans. Conclusions: Onychomycosis in HIV/AIDS patients presents various clinical manifestations and may be caused by emerging fungi. The peculiarities presented by different fungal agents justify the need for identification to species level, with the purpose of guiding better therapeutic approaches and minimizing these patients' exposure to conditions presenting a risk of disseminated infection. |
Databáze: | MEDLINE |
Externí odkaz: |